These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22206225)

  • 1. Insights into the mechanistic dichotomy of the protein farnesyltransferase peptide substrates CVIM and CVLS.
    Yang Y; Wang B; Ucisik MN; Cui G; Fierke CA; Merz KM
    J Am Chem Soc; 2012 Jan; 134(2):820-3. PubMed ID: 22206225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoprenoid diphosphate utilization by recombinant human farnesyl:protein transferase: interactive binding between substrates and a preferred kinetic pathway.
    Pompliano DL; Schaber MD; Mosser SD; Omer CA; Shafer JA; Gibbs JB
    Biochemistry; 1993 Aug; 32(32):8341-7. PubMed ID: 8347630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of protein farnesyltransferase specificity using "tunable" active site interactions: development of bioengineered prenylation pathways.
    Hougland JL; Gangopadhyay SA; Fierke CA
    J Biol Chem; 2012 Nov; 287(45):38090-100. PubMed ID: 22992747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upstream polybasic region in peptides enhances dual specificity for prenylation by both farnesyltransferase and geranylgeranyltransferase type I.
    Hicks KA; Hartman HL; Fierke CA
    Biochemistry; 2005 Nov; 44(46):15325-33. PubMed ID: 16285736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic studies of protein farnesyltransferase mutants establish active substrate conformation.
    Pickett JS; Bowers KE; Hartman HL; Fu HW; Embry AC; Casey PJ; Fierke CA
    Biochemistry; 2003 Aug; 42(32):9741-8. PubMed ID: 12911316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid residues that define both the isoprenoid and CAAX preferences of the Saccharomyces cerevisiae protein farnesyltransferase. Creating the perfect farnesyltransferase.
    Caplin BE; Ohya Y; Marshall MS
    J Biol Chem; 1998 Apr; 273(16):9472-9. PubMed ID: 9545274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxy-terminal CVLS-sequence-specific protein farnesyltransferase from the eyes of the shrimp Penaeus japonicus: purification and characterization.
    Wu CS; Chuang NN
    J Exp Zool; 1996 Aug; 275(5):346-54. PubMed ID: 8691187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro.
    James GL; Goldstein JL; Brown MS
    J Biol Chem; 1995 Mar; 270(11):6221-6. PubMed ID: 7890759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic studies of rat protein farnesyltransferase indicate an associative transition state.
    Huang C; Hightower KE; Fierke CA
    Biochemistry; 2000 Mar; 39(10):2593-602. PubMed ID: 10704208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein farnesyltransferase isoprenoid substrate discrimination is dependent on isoprene double bonds and branched methyl groups.
    Micali E; Chehade KA; Isaacs RJ; Andres DA; Spielmann HP
    Biochemistry; 2001 Oct; 40(41):12254-65. PubMed ID: 11591144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay of isoprenoid and peptide substrate specificity in protein farnesyltransferase.
    Reigard SA; Zahn TJ; Haworth KB; Hicks KA; Fierke CA; Gibbs RA
    Biochemistry; 2005 Aug; 44(33):11214-23. PubMed ID: 16101305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational analysis of a farnesyltransferase peptide inhibitor, CVIM.
    Carlacci L
    J Comput Aided Mol Des; 2000 May; 14(4):369-82. PubMed ID: 10815773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of Tyr361 beta to Leu in mammalian protein farnesyltransferase impairs product release but not substrate recognition.
    Spence RA; Hightower KE; Terry KL; Beese LS; Fierke CA; Casey PJ
    Biochemistry; 2000 Nov; 39(45):13651-9. PubMed ID: 11076503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-Ras peptide and protein substrates bind protein farnesyltransferase as an ionized thiolate.
    Hightower KE; Huang CC; Casey PJ; Fierke CA
    Biochemistry; 1998 Nov; 37(44):15555-62. PubMed ID: 9799520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesylation of nonpeptidic thiol compounds by protein farnesyltransferase.
    Hightower KE; Casey PJ; Fierke CA
    Biochemistry; 2001 Jan; 40(4):1002-10. PubMed ID: 11170422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein farnesyltransferase: kinetics of farnesyl pyrophosphate binding and product release.
    Furfine ES; Leban JJ; Landavazo A; Moomaw JF; Casey PJ
    Biochemistry; 1995 May; 34(20):6857-62. PubMed ID: 7756316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bivalent inhibitors for disrupting protein surface-substrate interactions and for dual inhibition of protein prenyltransferases.
    Machida S; Kato N; Harada K; Ohkanda J
    J Am Chem Soc; 2011 Feb; 133(4):958-63. PubMed ID: 21158442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent inhibition of protein farnesyltransferase by a benzodiazepine peptide mimetic.
    Roskoski R; Ritchie PA
    Biochemistry; 2001 Aug; 40(31):9329-35. PubMed ID: 11478901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction path of protein farnesyltransferase at atomic resolution.
    Long SB; Casey PJ; Beese LS
    Nature; 2002 Oct; 419(6907):645-50. PubMed ID: 12374986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of the alpha-secondary kinetic isotope effect for the reaction catalyzed by mammalian protein farnesyltransferase.
    Pais JE; Bowers KE; Fierke CA
    J Am Chem Soc; 2006 Nov; 128(47):15086-7. PubMed ID: 17117849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.